ResMed Inc (RMD)
218.57
-1.40
(-0.64%)
USD |
NYSE |
May 17, 16:00
218.62
+0.05
(+0.02%)
Pre-Market: 20:00
ResMed Revenue (Annual): 4.223B for June 30, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| June 30, 2023 | 4.223B |
| June 30, 2022 | 3.578B |
| June 30, 2021 | 3.197B |
| June 30, 2020 | 2.957B |
| June 30, 2019 | 2.607B |
| June 30, 2018 | 2.340B |
| June 30, 2017 | 2.067B |
| June 30, 2016 | 1.839B |
| June 30, 2015 | 1.679B |
| June 30, 2014 | 1.555B |
| June 30, 2013 | 1.514B |
| June 30, 2012 | 1.369B |
| June 30, 2011 | 1.243B |
| June 30, 2010 | 1.092B |
| June 30, 2009 | 920.74M |
| June 30, 2008 | 835.40M |
| Date | Value |
|---|---|
| June 30, 2007 | 716.33M |
| June 30, 2006 | 607.00M |
| June 30, 2005 | 425.50M |
| June 30, 2004 | 339.34M |
| June 30, 2003 | 273.57M |
| June 30, 2002 | 204.08M |
| June 30, 2001 | 155.16M |
| June 30, 2000 | 115.62M |
| June 30, 1999 | 88.60M |
| June 30, 1998 | 66.50M |
| June 30, 1997 | 49.20M |
| June 30, 1996 | 34.60M |
| June 30, 1995 | 23.50M |
| June 30, 1994 | 13.90M |
| June 30, 1993 | 7.70M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
2.607B
Minimum
2019
4.223B
Maximum
2023
3.312B
Average
3.197B
Median
2021
Revenue (Annual) Benchmarks
| Boston Scientific Corp | 14.24B |
| Align Technology Inc | 3.862B |
| Stryker Corp | 20.50B |
| Haemonetics Corp | 1.309B |
| Teleflex Inc | 2.974B |